212 related articles for article (PubMed ID: 7694159)
21. Effect of coronary perfusion of heptanol on conduction and ventricular arrhythmias in infarcted canine myocardium.
Callans DJ; Moore EN; Spear JF
J Cardiovasc Electrophysiol; 1996 Dec; 7(12):1159-71. PubMed ID: 8985805
[TBL] [Abstract][Full Text] [Related]
22. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
Zuanetti G; Corr PB
J Pharmacol Exp Ther; 1991 Jan; 256(1):325-34. PubMed ID: 1988663
[TBL] [Abstract][Full Text] [Related]
23. Nonsustained polymorphic ventricular tachycardia induced by electrical stimulation in 3 week old canine myocardial infarction.
Garan H; Fallon JT; Ruskin JN
Am J Cardiol; 1981 Aug; 48(2):280-6. PubMed ID: 7270437
[TBL] [Abstract][Full Text] [Related]
24. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
[TBL] [Abstract][Full Text] [Related]
25. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic factors conducive to experimental ventricular tachycardia.
Wetstein L; Mark R; Kaplinsky E; Mitamura H; Kaplan A; Sauermelch C; Michelson EL
Surgery; 1985 Sep; 98(3):532-9. PubMed ID: 4035573
[TBL] [Abstract][Full Text] [Related]
27. Inducibility of sustained ventricular tachycardia in a closed-chest ovine model of myocardial infarction.
Reek S; Bicknell JL; Walcott GP; Bishop SP; Smith WM; Kay GN; Ideker RE
Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):605-14. PubMed ID: 10234714
[TBL] [Abstract][Full Text] [Related]
28. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
[TBL] [Abstract][Full Text] [Related]
29. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
Patterson E; Amalfitano DJ; Lucchesi BR
J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974
[TBL] [Abstract][Full Text] [Related]
30. Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction.
Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR
Pharmacology; 1987; 35(4):181-93. PubMed ID: 3118399
[TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction.
Wallace AA; Stupienski RF; Heaney LA; Gehret JR; Lynch JJ
Am Heart J; 1991 May; 121(5):1413-21. PubMed ID: 1708198
[TBL] [Abstract][Full Text] [Related]
32. Facilitation of reentry by lidocaine in canine myocardial infarction.
Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
Acta Physiol Hung; 1994; 82(3):201-13. PubMed ID: 7717083
[TBL] [Abstract][Full Text] [Related]
33. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
Hashimoto H; Satoh N; Nakashima M
J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
[TBL] [Abstract][Full Text] [Related]
34. Intraindividual comparison of intravenous ajmaline and quinidine in patients with sustained ventricular tachycardia: effects on normal myocardium and on arrhythmia characteristics.
Lengfelder W; Senges J; Rizos I; Jauernig R; Brachmann J; von Ohlshausen K; Kübler W
Eur Heart J; 1985 Apr; 6(4):312-22. PubMed ID: 4029187
[TBL] [Abstract][Full Text] [Related]
35. Antidysrhythmic actions of meobentine sulfate.
Zimmerman JM; Patterson E; Pitt B; Lucchesi B
Am Heart J; 1984 Jun; 107(6):1117-24. PubMed ID: 6720538
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
[TBL] [Abstract][Full Text] [Related]
37. Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.
Patterson E; Gibson JK; Lucchesi BR
Pharmacology; 1988; 36(2):73-83. PubMed ID: 3353442
[TBL] [Abstract][Full Text] [Related]
38. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
[TBL] [Abstract][Full Text] [Related]
39. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
[TBL] [Abstract][Full Text] [Related]
40. Comparison of effects of three anesthetic agents on induction of ventricular tachycardia in a canine model of myocardial infarction.
Hunt GB; Ross DL
Circulation; 1988 Jul; 78(1):221-6. PubMed ID: 3383405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]